Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proteomic Profiling to Reveal Novel Prognostic Markers for Neurological Outcome Following Resuscitation

NCT01960699 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT01960699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01960699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proteomic Profiling to Reveal Novel Prognostic Markers for Neurological Outcome Following Resuscitation
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Completed
Start date
October 31, 2013
Completion date
January 31, 2020
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest with successful resuscitation